These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8427450)

  • 61. Idiopathic narcolepsy: effect of naloxone studied in one of three patients with unelevated beta-endorphin-like immunoreactivity plasma levels.
    Pasi A; Wettstein A; Foletta D; Gramsch C
    J Clin Psychopharmacol; 1982 Jun; 2(3):216-7. PubMed ID: 6284804
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cardiogenic shock in acute myocardial infarction].
    Martínez A; Corbalán R; González R; Asenjo R; Illanes G; Rodríguez JA
    Rev Med Chil; 1986 Oct; 114(10):947-53. PubMed ID: 2883711
    [No Abstract]   [Full Text] [Related]  

  • 63. [Cardiogenic shock following acute myocardial infarct (current attitudes on pathology, physiopathology and therapy)].
    Modrić B; Rukavina Z
    Vojnosanit Pregl; 1976 Nov; 33(6):419-24. PubMed ID: 1014408
    [No Abstract]   [Full Text] [Related]  

  • 64. Myocardial reperfusion after acute occlusion of the left main coronary artery.
    Salvi A; Klugmann S; Della Grazia E; Maras P; Camerini F
    Am J Cardiol; 1983 Jun; 51(10):1791. PubMed ID: 6858888
    [No Abstract]   [Full Text] [Related]  

  • 65. [High-dose nitroglycerin in cardiogenic shock].
    Guglina ME
    Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Letter: Methylprednisolone in acute myocardial infarction.
    Feola M
    Am J Cardiol; 1975 Oct; 36(4):539-40. PubMed ID: 1190066
    [No Abstract]   [Full Text] [Related]  

  • 67. Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
    Lvoff R; Wilcken DE
    Circulation; 1972 Mar; 45(3):534-42. PubMed ID: 4401050
    [No Abstract]   [Full Text] [Related]  

  • 68. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis.
    Orban M; Limbourg T; Neumann FJ; Ferenc M; Olbrich HG; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H; Hausleiter J
    EuroIntervention; 2016 Dec; 12(11):e1395-e1403. PubMed ID: 26690314
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extent of ischemic stimulus and plasma beta-endorphin levels in silent myocardial ischemia.
    Hikita H; Etsuda H; Takase B; Satomura K; Kurita A; Nakamura H
    Am Heart J; 1998 May; 135(5 Pt 1):813-8. PubMed ID: 9588410
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma beta-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal.
    Antonio Martínez J; Vargas ML; Fuente T; Del Rio Garcia J; Milanés MV
    Eur J Pharmacol; 1990 Jun; 182(1):117-23. PubMed ID: 2144820
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cardiac insufficiency and shock caused by acute myocardial infarction. Manipulation of hemodynamic parameters].
    Campagna C; Franco L; Perniola V
    Minerva Anestesiol; 1983 Nov; 49(11):653-8. PubMed ID: 6669276
    [No Abstract]   [Full Text] [Related]  

  • 74. Shenfu Injection () inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock.
    Jin YY; Gao H; Zhang XY; Ai H; Zhu XL; Wang J
    Chin J Integr Med; 2017 Mar; 23(3):170-175. PubMed ID: 28028723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The treatment of cardiogenic shock. V. The use of corticosteroids in the treatment of cardiogenic shock.
    Dietzman RH; Lillehei RC
    Am Heart J; 1968 Feb; 75(2):274-7. PubMed ID: 4951324
    [No Abstract]   [Full Text] [Related]  

  • 76. [Emergency therapy in acute coronary insufficiency and a recent heart infarction].
    Geissler W
    Dtsch Gesundheitsw; 1970 Nov; 25(45):2127-32. PubMed ID: 5487973
    [No Abstract]   [Full Text] [Related]  

  • 77. [Fibrinolysis in acute myocardial infarct with increased risk].
    Benda L; Klösel W; Spiess A; Zenz W
    Wien Z Inn Med; 1973; 54(10):454-65. PubMed ID: 4803402
    [No Abstract]   [Full Text] [Related]  

  • 78. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-dose oral pimobendan emancipates patients with severe ischemic pump failure from intravenous catecholamine infusion for cardiogenic shock.
    Koizumi T; Taguchi S
    Int J Cardiol; 2016 Jan; 202():829-30. PubMed ID: 26476040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.